Lapachol

Lapachol is a naturally occurring naphthoquinone extracted primarily from the heartwood of Tabebuia (pau d'arco) trees. It exerts biological activity largely by generating reactive oxygen species and inhibiting mitochondrial electron transport chain enzymes, disrupting cellular respiration in parasitic and tumor cells.

Origin & History

Lapachol is a natural naphthoquinone compound extracted from the inner bark of the lapacho tree, known botanically as Handroanthus impetiginosus. It is native to Central and South America, particularly Brazil, where it's traditionally called 'pau d'arco'.

Historical & Cultural Context

Lapachol is derived from the lapacho tree, traditionally used in Brazilian folk medicine. Known as 'pau d'arco,' it has been used in Central and South America for unspecified traditional applications.

Health Benefits

• Antitumor activity, based on preliminary studies. • Trypanocidal effects, suggested by in vitro research. • Molluscicidal properties, observed in laboratory settings. • Leishmanicidal activity, indicated by experimental studies. • Antifungal effects, supported by early research.

How It Works

Lapachol inhibits mitochondrial NADH-ubiquinone oxidoreductase (Complex I) and succinate dehydrogenase (Complex II), blocking ATP synthesis in susceptible cells. It also undergoes redox cycling to generate superoxide radicals and hydrogen peroxide, inducing oxidative stress that damages DNA and lipid membranes in tumor and parasite cells. Additionally, lapachol intercalates into DNA and inhibits topoisomerase II, interfering with replication in rapidly dividing cells.

Scientific Research

The research dossier does not contain specific human clinical trials or meta-analyses documenting lapachol's efficacy in human subjects. Further peer-reviewed studies are necessary to establish clinical evidence.

Clinical Summary

Most evidence for lapachol comes from in vitro and animal studies; robust human clinical trials are largely absent. A Phase I human trial conducted in the 1970s by the U.S. National Cancer Institute evaluated lapachol in cancer patients but was terminated early due to dose-limiting toxicities including anticoagulation and gastrointestinal effects before efficacy endpoints could be reliably assessed. In rodent models, lapachol demonstrated significant tumor growth inhibition against Walker 256 carcinosarcoma, though effective doses approached toxic thresholds. The current evidence base is preliminary, and lapachol cannot be recommended as a therapeutic agent without further controlled human trials.

Nutritional Profile

Lapachol (C15H14O3) is a naturally occurring naphthoquinone compound, not a dietary nutrient, and therefore lacks conventional macronutrient or micronutrient profiles. Molecular weight: 242.27 g/mol. It is not a source of protein, carbohydrates, dietary fiber, or conventional vitamins/minerals. Bioactive composition: Primary compound is 2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone at near-100% purity in isolated form. Naturally found in the heartwood of Tabebuia (Handroanthus) species (pau d'arco bark), where it constitutes approximately 2–7% of dry heartwood weight alongside related naphthoquinones including beta-lapachone and xyloidone. Lapachol exhibits high lipophilicity (logP approximately 3.0–3.5), contributing to poor aqueous solubility (approximately 0.03 mg/mL in water at physiological pH), which significantly limits oral bioavailability. It is better absorbed in alkaline intestinal environments and undergoes hepatic first-pass metabolism. In pau d'arco preparations (teas, tinctures), lapachol concentration is typically low (often below 1 mg per serving) due to its poor water solubility, meaning most commercial herbal preparations contain subtherapeutic levels. No dietary reference intakes (DRIs) exist. Concentrated supplemental or pharmaceutical doses studied in research contexts range from 1.5 to 15 mg/kg body weight, with toxicity (anticoagulant effects, nausea) reported at higher clinical doses.

Preparation & Dosage

The search results do not provide information on clinically studied dosage ranges or standardization protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

β-lapachone, α-lapachone, quercetin, resveratrol, curcumin

Safety & Interactions

Lapachol carries a significant safety concern: it is a vitamin K antagonist and can produce dose-dependent anticoagulation, causing prolonged prothrombin times similar to warfarin. Doses above approximately 1.5–2 mg/kg/day in humans produced nausea, vomiting, and bleeding risk in the NCI trial, leading to study discontinuation. Lapachol should not be combined with anticoagulants such as warfarin, heparin, or antiplatelet drugs due to additive bleeding risk. It is contraindicated in pregnancy, as animal studies indicate embryotoxic and teratogenic potential, and it should be avoided by individuals with clotting disorders or those scheduled for surgery.